Summary: In this interview with Pharmtech, Karunakar Sukuru, Global Vice President, Rx Product Development, Pharma and Consumer Health, Catalent shares his thoughts on the key benefits of Lipid based formulations (LBF) and how this technology offers flexibility and manufacturing in context of scale up in comparison to some of the more conventional dosage forms.​